CASP3 and lip and oral cavity carcinoma: Resistance to chemotherapy and radiotherapy reduces caspase-3 activation, highlighting its importance as a therapeutic target (Varışlı et al. 2023). DAS has substantial pro-apoptotic effect on oral cancer cells, specifically YD-38 and HSC-3 cell lines.